Log in
Enquire now
Instylla

Instylla

Instylla is a Waltham, Massachusetts-based diagnostic tools company developing solutions for embolization and founded in 2017 by Amarpreet Sawhney.

OverviewStructured DataIssuesContributors

Contents

instyllainc.com
instylla.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Biotechnology
Biotechnology
Diagnostic tools
Diagnostic tools
Location
Bedford, Massachusetts
Bedford, Massachusetts
Waltham, Massachusetts
Waltham, Massachusetts
United States
United States
B2X
B2B
B2B
0
CEO
‌
Amarpreet Sawhney
Founder
‌
Amarpreet Sawhney
Pitchbook URL
pitchbook.com/profiles...181973-08
Number of Employees (Ranges)
11 – 500
Investors
Excelestar Ventures
Excelestar Ventures
Incept
Incept
Catalyst Health Ventures
Catalyst Health Ventures
‌
AMED Ventures
Sparta Group
Sparta Group
Ascension Ventures
Ascension Ventures
Founded Date
2017
Total Funding Amount (USD)
33,500,000
Latest Funding Round Date
October 15, 2020
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
25,400,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Instylla

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.